Periodic Reporting for period 6 - BIOVALID (Clinical validation of the DiviTum assay in two high profile clinical studies in Europe)

Clinicians need better predictive and monitoring tools to administer optimal treatments for cancer patients and evaluate who actually responds to therapy. Drug developers face high risk of regulatory failure due to not being able to use better tools for selection and...